Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
It all started with CAR-T cells. Or did it? Dive into the future of biotechnology by […]
Once a flourishing beacon of innovation and global leadership, Japan’s pharmaceutical industry has encountered significant headwinds […]
Japan is a beacon of innovation globally, especially in the pharmaceutical sector. Notably, the rise of […]